Fig. 1

Flowchart of the study. APS: antiphospholipid syndrome, CYC: cyclophosphamide, LN: lupus nephritis, MMF: mycophenolate mofetil, n: number of patients, SLE: systemic lupus erythematosus, TMA: thrombotic microangiopathy
Flowchart of the study. APS: antiphospholipid syndrome, CYC: cyclophosphamide, LN: lupus nephritis, MMF: mycophenolate mofetil, n: number of patients, SLE: systemic lupus erythematosus, TMA: thrombotic microangiopathy